Investing.com - European stocks slipped marginally lower Thursday, with investors digesting more corporate earnings ahead of an eagerly-awaited Bank of England policy decision. At 03:05 ET (08:05 GMT) ...

Read More »

FTSE 100 outlook: Can the blue chip index target the 10,000 mark?

We look at whether the FTSE 100 can reignite its upside momentum and make a run at the psychological 10,000 mark ...

Read More »

EU panel backs Enhertu for certain breast cancers

LONDON - AstraZeneca PLC (LON:AZN) and Daiichi Sankyo's Enhertu has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

Read More »

AstraZeneca's (LON:AZN) investors will be pleased with their respectable 55% return over the last five years

AstraZeneca PLC (LON:AZN) shareholders might be concerned after seeing the share price drop 11% in the last quarter. On the bright side the returns have been quite good over the last half decade.

Read More »

AstraZeneca CEO buys 20,000 company shares at £102.03 each

AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN) disclosed today that Pascal Soriot, the Chief Executive Officer, has purchased 20,000 ordinary shares of the company for £102.03 per share. The transaction ...

Read More »